ZYNTEGLO™ (betibeglogene autotemcel)
| Full Name | ZYNTEGLO™ (betibeglogene autotemcel) |
| Drug | betibeglogene autotemcel |
| Manufacturer | Genetix Biotherapeutics Inc. |
| Route of Administration | Intravenous |
| Site of Care | Healthcare Facility |
| Approved Indication | The treatment of adult and pediatric patients with β-thalassemia who require regular red blood cell (RBC) transfusions |
| Disease | Transfusion-dependent β-thalassemia (TDT) |
| Therapeutic Area | Hematology; Cell & Gene Therapy |
| Enrollment Information | Visit zynteglohcp.com |
| Phone Number | 847-849-1588 |
| Fax Number | 877-860-1726 |
| Website | zynteglohcp.com |